To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease

被引：0
|
作者：
Behr, Juergen [1 ,2 ]
机构：
[1] LMU Univ Hosp, Dept Med 5, Munich, Germany
[2] German Ctr Lung Res, Munich, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 208卷 / 09期
关键词：
IDIOPATHIC PULMONARY-FIBROSIS; DOUBLE-BLIND; PIRFENIDONE; UPDATE;
D O I：
10.1164/rccm.202308-1523ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：949 / 951
页数：4
相关论文
共 50 条
  • [21] Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease
    Myall, Katherine J.
    West, Alex G.
    Martinovic, Jennifer L.
    Lam, Jodie L.
    Roque, Diana
    Wu, Zhe
    Maher, Toby M.
    Molyneaux, Philip L.
    Suh, Eui-Sik
    Kent, Brian D.
    CHEST, 2023, 164 (05) : 1232 - 1242
  • [22] Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
    Nasser, Mouhamad
    Larrieu, Sophie
    Boussel, Loic
    Si-Mohamed, Salim
    Bazin, Fabienne
    Marque, Sebastien
    Massol, Jacques
    Thivolet-Bejui, Francoise
    Chalabreysse, Lara
    Maucort-Boulch, Delphine
    Hachulla, Eric
    Jouneau, Stephane
    Le Lay, Katell
    Cottin, Vincent
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [23] Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    Perrotta, Fabio
    Zamparelli, Stefano Sanduzzi
    D'Agnano, Vito
    Montella, Antonia
    Fomez, Ramona
    Pagliaro, Raffaella
    Schiattarella, Angela
    Cazzola, Mario
    Bianco, Andrea
    Mariniello, Domenica Francesca
    BIOMEDICINES, 2024, 12 (07)
  • [24] Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease
    Nishioka, Yasuhiko
    Araya, Jun
    Tanaka, Yoshiya
    Kumanogoh, Atsushi
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [25] Diagnosing complications and co-morbidities of fibrotic interstitial lung disease
    Margaritopoulos, George A.
    Kokosi, Maria A.
    Wells, Athol U.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (07) : 645 - 658
  • [26] Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
    Guler, Sabina A.
    Machahua, Carlos
    Geiser, Thomas K.
    Kocher, Gregor
    Marti, Thomas M.
    Tan, Benjamin
    Trappetti, Verdiana
    Ryerson, Christopher J.
    Funke-Chambour, Manuela
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [27] Complications of fibrotic interstitial lung disease for the general radiologist
    Watson, S.
    Dixon, G.
    Savill, A.
    Gibbons, M. A.
    Barratt, S. L.
    Rodrigues, J. C. L.
    CLINICAL RADIOLOGY, 2024, 79 (05) : 323 - 329
  • [28] Update in the diagnostic approach to fibrotic interstitial lung disease
    Johannson, Kerri A.
    Hambly, Nathan
    Assayag, Deborah
    Ryerson, Christopher J.
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2019, 3 (03) : 155 - 159
  • [29] Interstitial Lung Disease 2021 2 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
    Spagnolo, Paolo
    Ryerson, Christopher J.
    Putman, Rachel
    Oldham, Justin
    Salisbury, Margaret
    Sverzellati, Nicola
    Valenzuela, Claudia
    Guler, Sabina
    Jones, Steve
    Wijsenbeek, Marlies
    Cottin, Vincent
    LANCET RESPIRATORY MEDICINE, 2021, 9 (09): : 1065 - 1076
  • [30] Cough in Fibrotic Interstitial Lung Disease: Effects and Implications
    Channick, Jessica E.
    Swigris, Jeff
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (08) : 975 - 976
12345